Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Plotinus's Profile
Displaying 101-150 of 645 result(s).
CYDY CytoDyn Inc
08/23/2024 4:43:35 PM
My memory if accurate was a 90 day (12)
CYDY CytoDyn Inc
08/23/2024 2:52:35 PM
“ intended to convey a speculativ (15)
CYDY CytoDyn Inc
08/23/2024 11:56:34 AM
Cytodyn may well be engaging Syneos (14)
CYDY CytoDyn Inc
08/15/2024 11:54:13 AM
This observation in the second hype (12)
CYDY CytoDyn Inc
08/15/2024 11:21:34 AM
Excellent summary OHM20. There is s (5)
CYDY CytoDyn Inc
08/14/2024 11:37:15 AM
Warning, objects are closer than th (12)
CYDY CytoDyn Inc
08/14/2024 8:36:59 AM
Assuming for a minute the MSS CRC t (10)
CYDY CytoDyn Inc
08/13/2024 6:47:06 PM
Add in the bone marrow suppression (8)
CYDY CytoDyn Inc
08/13/2024 5:36:05 PM
Again, clarity will come when the t (8)
CYDY CytoDyn Inc
08/13/2024 4:22:22 PM
It will be useful to get clarificat (18)
CYDY CytoDyn Inc
08/12/2024 10:25:11 AM
I agree with Respert, buttoning dow (28)
CYDY CytoDyn Inc
07/23/2024 3:45:37 PM
The FDA doesn’t slap a black box (8)
CYDY CytoDyn Inc
07/23/2024 11:52:28 AM
As a clinician his primary interest (15)
CYDY CytoDyn Inc
07/18/2024 5:03:11 PM
“CCR5 and CCL5 in metastatic colo (16)
CYDY CytoDyn Inc
07/17/2024 3:01:57 PM
The thing that turns investors head (10)
CYDY CytoDyn Inc
07/10/2024 5:12:52 PM
“Honestly, there's no power or be (10)
CYDY CytoDyn Inc
07/10/2024 4:18:07 PM
Lupus is on OHM’s indication list (3)
CYDY CytoDyn Inc
07/09/2024 8:57:40 AM
“The real money will come from se (9)
CYDY CytoDyn Inc
07/09/2024 8:50:39 AM
While the settlement IMHO comes now (10)
CYDY CytoDyn Inc
07/09/2024 8:34:27 AM
You should separate out trial desig (3)
CYDY CytoDyn Inc
07/01/2024 5:02:26 PM
I just reviewed Dr Noureddin’s NA (13)
CYDY CytoDyn Inc
06/28/2024 2:38:21 PM
I have been musing today and believ (27)
CYDY CytoDyn Inc
06/28/2024 11:44:08 AM
I would be a little surprised if Dr (15)
CYDY CytoDyn Inc
06/27/2024 10:09:44 AM
There will be an opportunity to sta (11)
CYDY CytoDyn Inc
06/27/2024 9:56:17 AM
The irony of hepatotoxicity with el (13)
CYDY CytoDyn Inc
06/24/2024 1:24:36 PM
Going with PET also as most likely. (3)
CYDY CytoDyn Inc
06/24/2024 10:51:46 AM
Just looked back at the conference (2)
CYDY CytoDyn Inc
06/24/2024 10:44:02 AM
I would not hazard a guess here but (2)
CYDY CytoDyn Inc
06/21/2024 1:06:39 PM
“It really upsets me that the FDA (13)
CYDY CytoDyn Inc
06/18/2024 2:05:31 PM
May 29th we were at 29 cents. Fails (9)
CYDY CytoDyn Inc
06/18/2024 9:41:57 AM
I don’t think Gamma wave stimulat (6)
CYDY CytoDyn Inc
06/17/2024 2:47:50 PM
“activation of CCR5 and the accom (13)
CYDY CytoDyn Inc
06/17/2024 11:56:22 AM
Another chink and the amyloid hypot (13)
CYDY CytoDyn Inc
06/13/2024 11:34:55 AM
“So if you short a million shares (6)
CYDY CytoDyn Inc
06/13/2024 11:11:55 AM
“GLUT-1 : A glucose transporter, (11)
CYDY CytoDyn Inc
06/12/2024 2:43:03 PM
“ Because of the lack of any adeq (8)
CYDY CytoDyn Inc
06/11/2024 10:26:30 PM
If you are referring to Gileads lon (7)
CYDY CytoDyn Inc
06/11/2024 12:35:56 PM
Someone floated the idea warrant ho (6)
CYDY CytoDyn Inc
06/11/2024 8:34:50 AM
I hope they don’t pair Leronlimab (13)
CYDY CytoDyn Inc
06/10/2024 4:56:23 PM
Ohm20, interesting thesis. You migh (7)
CYDY CytoDyn Inc
06/06/2024 7:49:20 PM
When we get the kind of news for wh (2)
CYDY CytoDyn Inc
06/06/2024 1:15:41 PM
I think it’s the antithesis of ab (14)
CYDY CytoDyn Inc
06/05/2024 2:12:26 PM
Just out re IBD from Nature (I beli (11)
CYDY CytoDyn Inc
06/05/2024 9:11:38 AM
Footnote: per this abstract from th (13)
CYDY CytoDyn Inc
06/05/2024 8:46:31 AM
I believe you are right. Primary br (2)
CYDY CytoDyn Inc
06/04/2024 1:21:33 PM
Hi, I’m Plotinus and I have a dis (28)
CYDY CytoDyn Inc
06/03/2024 2:21:57 PM
I agree…would be nice if NIH step (9)
CYDY CytoDyn Inc
06/02/2024 8:00:18 PM
“At one time I thought of trackin (9)
CYDY CytoDyn Inc
06/01/2024 8:46:46 AM
“The next bastion to be conquered (19)
CYDY CytoDyn Inc
05/31/2024 5:36:04 PM
“lightning in a bottle” We here (5)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • AI Adoption in Asia Pacific: Navigating Opportunities and Challenges
  • Unilumin's Role in the Award-Winning China Pavilion at Expo 2025
  • Exciting Developments in RNA Therapeutics: Wave Life Sciences' Progress
  • A Decade of Luxury: The Reverie Saigon’s Remarkable Journey
  • Hurricane Melissa: GAP Provides Updates on Airport Operations
  • Five Key Stocks Capturing Investor Interest Recently
  • Raytech Holding Limited Implements Share Consolidation Plan
  • Marex Group Investors: Important Class Action Update
  • Meta's AI Transformation Under Zuckerberg: A Bright Future Ahead
  • Cryptocurrency Markets React to Fed Chair Powell's Comments
  • LG Energy Solution's Impressive Q3 2025 Performance Highlights
  • Securities Class Action Filed Against Wildermuth Fund and Auditor
  • Fluor Corporation Shareholder Update: Class Action Lawsuit Insights
  • KBR Investors Face Class Action: Critical Deadline Approaching
  • James Hardie Investors Alert: Key Deadline Approaches Fast
  • Cytokinetics Facing Class Action - Key Information for Investors
  • Molina Healthcare Investors: Important Legal Updates and Guidance
  • TeraWulf Inc. Boosts and Prices $900 Million Convertible Notes
  • Investors Alert: Class Action Lawsuit Against WPP plc Overview
  • LG Energy Solution's Q3 2025 Financial Highlights Unveiled
  • Vista Expands XO Services in Asia to Meet Aviation Demand
  • Hollyland Empowers Young Creators with Sound Campus Initiative
  • TeraWulf Secures $900 Million for Growth Through Notes Offering
  • New Virtual Program Aims to Solve Car Seat Installation Issues
  • Jamie Dimon on Office Culture: Young Employees at Risk
  • Enhancing Sino-Korean Literary Ties Through Cultural Exchanges
  • Cohen Veterans Network Marks 5 Years of Service Expansion in Hawaii
  • Athabasca Oil Corporation's Thriving Q3 2025 Financial Snapshot
  • Athabasca Oil's Q3 2025 Report: Solid Growth Amid Market Challenges
  • Universal Music Group Partners with Udio for AI Music Innovation
  • Elevating Patient Care: Freedom Surgical Center's New Partnership
  • IQAX and CargoNPay Innovate with AI in Shipping Solutions
  • Ubiqconn Technology Showcases Innovations at Global Conference
  • Innovative Heart Valve Solutions Revealed at Leading Conference
  • ArkBio Advances Monoclonal Antibody Study to Combat RSV
  • Global Expansion of Chinese E-commerce During Singles Day
  • Biltmore's Enchanted Christmas Celebrations Through History
  • Celebrate the Magic of the Holidays at Biltmore Estate
  • Rubicon Organics Set to Share Q3 2025 Financial Results Soon
  • Envista Holdings Posts Impressive Q3 2025 Earnings Results
  • Innovative Partnership Between Universal Music and Udio Unveiled
  • Celebrating Talent: Latham & Watkins Promotes New Leaders
  • Energizer Holdings, Inc. Announces Upcoming Investor Webcast
  • Stride, Inc. Faces Scrutiny as Allegations Emerge
  • Rubicon Organics Unveils Q3 2025 Financial Results Details
  • Baxter International, Inc. Investors Encouraged to Act Now
  • Exploring ASC36: A Breakthrough in Obesity Treatment
  • Canton Fair Showcases Agricultural Innovations and Safety
  • Canton Fair Showcases Innovation in Agriculture Sustainability
  • Transforming Building Materials with Threekit AI Solutions
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site